Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation

Transplantation

Volumn 62, Issue 6, 1996, Pages 810-818

  Van Gelder, Michel ^a,b   Mulder, Andries H ^a,c   Van Bekkum, Dick W ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

^b St Clara Hospital   (Netherlands)

^c Pathologisch Lab V Dordrecht eo   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HLA MATCHING; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENCE RISK; T LYMPHOCYTE ACTIVATION;

EID: 0029743390     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609270-00019     Document Type: Article

References (65)

1. Raine CS. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984; 50: 608.
2. Pender MP. Demyelination and neurological signs in experimental allergic encephalomyelitis. J Neuroimmunol 1987; 15: 11.
3. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt1+2-T lymphocytes. J Immunol 1981; 127: 1420.
4. Katz D, Taubenberger JK, Canella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661.
5. Pender MP, Stanley GP, Yoong G, Nguyen KB. The neuropoathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A. Acta Neuropathol 1990; 80: 172.
6. Van Gelder M, Van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995; 16: 343.
7. Van Gelder M, Kinwell-Bohré EPM, Mulder AH, Van Bekkum DW. Both bone marrow and non-bone marrow associated factors determine susceptibility to experimental autoimmune encephalomyelitis of BUF and WAG rats. Cell Immunol 1996; 68: 39
8. Drobyski WR, Ash RC, Casper JT, et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980.
9. Wonigeit K, Lambracht D. Kunz H, Gill T III, Hedrig HJ. Characterization of a new recombinant RT1 haplotype (r37) in BN.1B/Pit rats. Transplant Proc 1993; 25: 2763.
10. Kunz HW, Cramer DV, Gill TJ III. Comparison of RT1 haplotypes using congenic lines. Transplant Proc 1981; 23: 1494.
11. Dallman MJ, Thomas ML, Green JR. MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. Eur J Immunol 1984; 14: 260.
12. Jefferies WA, Green JR, Williams AF. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med 1985; 165: 117.
13. Robinson AP, Puklavex M, Mason D. MRC OX-52: a rat T-cell antigen. Immunology 1986; 57: 527.
14. Hünig T, Wallay HJ, Hartley JK. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. J Exp Med 1989; 169: 73.
15. Dijkstra CD, Dopp, EA, Joling P, Kraal G. The heterogenity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54: 589.
16. Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993; 7: 19.
17. Paterson DJ, Jeffries WA, Green JR, et al. Antigens of activated rat lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987; 24: 1281.
18. Kampinga J, Kroese FGM, Pol GH, et al. RT7-defined alloantigens in rats are part of the leucocyte common antigen family. Scand J Immunol 1990; 31: 699.
19. Van Gelder M, Kinwel-Bohré EPM, Van Bekkum, DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993; 11: 233.
20. Brock N, Pohl J The development of mesna for regional detoxification. Cancer Treat Rev 1983; 10 (suppl A): 33.
21. Mostarica-Stojkovic M, Petrovic M, Lukic ML. Resistance to the induction of EAE in AO rats: its prevention by the pre-treatment with cyclophosphamide or low dose of irradiation. Clin Exp Immunol 1982; 50: 311.
22. Hickey WF, Gonatas NK, Kimura H, Wilson DB. Identification and quantitation of T lymphocyte subsets in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol 1983; 131: 2805.
23. Hickey WF. T-cell entry and antigen presentation in the central nervous system. In: Ader RD, Felten DA, Cohen NK, eds. Psychoneuroimmunology, New York: Academic, 1991: 149.
24. Matsumoto Y, Fujiwara M. Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J Neuroimmunol 1987; 17: 71.
25. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
26. Skundric DS, Kim C, Tse HY, Raine CS. Homing of T cells to the crentral nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice. J Neuroimmunol 1993; 46: 113.
27. Naparstek Y, Ben-Nun A, Holoshitz J, et al. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE): functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol 1983; 13: 418.
28. Ludowyk PA, Willenborg DO, Parish CR. Selective localisation of neuro-specific T lymphocytes in the central nervous system. J Neuroimmunol 1992; 37: 237.
29. + T cells that induce experimental allergic encephalomyelitis. J Neuroimmunol 1992; 40: 57.
30. Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersnsitivity reaction. J Exp Med 1987; 165: 1058.
31. Hayosh NS, Swanborg RH. Autoimmune effector cells: IX. Inhibition of adoptive transfer of autoimmnune encephalomyelitis with a monoclonal antibody specific for Interleukin 2 receptors. J Immunol 1987; 138: 3771.
32. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28: 254.
33. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin, Heidelberg: Springer, 1983: 37.
34. Dalakas M, Wright RG, Prineas JW. Nature of the reversible white matter lesion in multiple sclerosis. Effects of acute inflammation on myelinated tissue in the rabbit eye. Brain 1980; 103: 515.
35. Youl BD, Turano G, Towell AD, et al. The pathophysiology of acute optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437.
36. Daniel PM, Lam DKC, Pratt OE. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis. J Neurol Sci 1981; 52: 211.
37. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho E-S. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137.
38. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho E-S. Multiple sclerosis: pathology of recurrent lesions. Brain 1993; 116: 681.
39. Vandenbark AA, Naliver G, Konat G, Teal P, Offner H. Chronic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines. J Neurosci Res 1986; 16: 643.
40. Linington C, Engelhardt B, Kapocs G, Lassmann H. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992; 40: 219.
41. Hughes R. Immunotherapy for multiple sclerosis. J Neurol Neurosurg Psychiatry 1994; 57: 3.
42. Ebers GC. Treatment of multiple sclerosis. Lancet 1994; 343: 275.
43. Rudge P, Koetsier JC, Mertin J, et al. Randomised double blind controlled trial of cyclosporin in multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 559, 932 (erratum).
44. Weiner HL, Mackin GA, Orav EJ, et al. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology 1993; 43: 910.
45. Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J, Beutler E. Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 1994; 344: 9.
46. Busca A, Anasetti C, Anderson G, et al. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 1994; 83: 3077.
47. Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20: 1043.
48. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986; 1: 237.
49. Lowenthal RM, Cohen ML, Atkinson K, Biggs J Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993; 20: 137.
50. Liu Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1992; 9: 31.
51. Eedy DJ, Burrows D, Bridges, JM, Jones FGC. Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J. 1990; 300: 908.
52. Mant MJ, Russell AS, Percy JS, Davis P, Messner HA. Immunosuppression as intial treatment for gold induced aplastic anemia. J Rheumatol 1987; 14: 1026.
53. Tienari PJ, Salonen O, Wilkström J, Valanne L, Palo J Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 1992; 55: 883.
54. Gasser DL, Palm J, Gonatas K. Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 1973; 181: 872.
55. Williams RM, Moore MJ. Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med 1973; 138: 775.
56. Saoudi A, Kuhn J, Huygen K, et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 1993; 23: 3096.
57. Racke MK, Bonomo A, Scott DE, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994; 180: 1961.
58. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis age-corrected empiric risks for children and siblings of patients. Neurology 1988; 38: 990.
59. Ebers GC, Paty DW, Stiller CR, et al. HLA-typing in multiple sclerosis sibling pairs. Lancet 1982; ii: 88.
60. Govaerts AG, Martin-Mondi[unl]ere C, Poirier JC, et al. HLA and multiple sclerosis: population and families study. Tissue Antigens 1985; 25: 187.
61. Francis DA, Batchelor JR, McDonald WI, et al. HLA genetic determinants in familial MS. Tissue Antigens 1987; 29: 7.
62. Löwenberg B, Wagemaker G, Van Bekkum DW, et al. Graftversus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplant 1986; 1: 133.
63. Van Bekkum DW. Biological apects and clinical implications of GvHD: Proceedings of the international symposium - bone marrow transplantation from alternative donors: biology, clinical results, registry activities. Bone Marrow Transplant 1993; 11 suppl 1: 99.
64. Hale G, Waldmann H, for CAMPATH users. CAMPATH-1 monoclonal antibodies in bone marrow transplantation. J Haematother 1994; 3: 15.
65. Mendez MF, Pogacar S. Malignant monophasic multiple sclerosis or "Marburg's disease". Neurology 1988; 38: 1153.